跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle
Approved
STANDARD
FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8853e0970916e472
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
8853e0970916e472
Product Name
FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle
Artg Id
106962
Artg Name
FOSRENOL lanthanum 750mg (as lanthanum carbonate hydrate) chewable tablet bottle
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2005-11-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/46538311e89d765e8e8ca5a150c19b7a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7948d10b09f4ae65f414f4f8755dcf20.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8853e0970916e472
Type
Standard
Back to TGA Approvals